NCT02671721

Brief Summary

The purpose of this pilot study is to identify the optimal way to ventilate patients during abdominal surgery in order to reduce the amount of post-operative pulmonary complications in patients at moderate and high-risk for them.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 30, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 2, 2016

Completed
4 months until next milestone

Study Start

First participant enrolled

June 1, 2016

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2017

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2017

Completed
Last Updated

February 8, 2019

Status Verified

February 1, 2019

Enrollment Period

9 months

First QC Date

January 30, 2016

Last Update Submit

February 6, 2019

Conditions

Outcome Measures

Primary Outcomes (4)

  • Intraoperative driving pressure

    We will assess intraoperative driving pressure to evaluate respiratory mechanics during surgery.

    During abdominal surgery

  • Intraoperative transpulmonary pressure

    We will assess intraoperative transpulmonary pressure to evaluate respiratory mechanics during surgery.

    During abdominal surgery

  • Intraoperative respiratory system compliance

    We will assess intraoperative respiratory system compliance to evaluate respiratory mechanics during surgery.

    During abdominal surgery

  • Intraoperative positive end-expiratory pressure (PEEP) levels

    We will assess intraoperative PEEP values and their variability between patients and during surgery.

    During abdominal surgery

Secondary Outcomes (3)

  • Intraoperative gas exchange

    During abdominal surgery

  • Plasma levels of biomarkers of lung injury

    During abdominal surgery

  • Postoperative Pulmonary Complications

    Within the first 7 postoperative days.

Study Arms (3)

Conventional Strategy

NO INTERVENTION

Patients will receive usual and prudent PEEP and tidal volume settings.

Maximal Compliance Strategy

EXPERIMENTAL

PEEP will be set at the maximum static respiratory system compliance during a descending PEEP titration curve.

Other: Maximal Compliance

Transpulmonary Pressure Strategy

EXPERIMENTAL

Personal PEEP titration using transpulmonary pressures obtained from a naso/orogastric tube containing an esophageal balloon port

Other: Transpulmonary Pressure

Interventions

PEEP will be set at the maximum static respiratory system compliance during a descending PEEP titration curve.

Maximal Compliance Strategy

We will use transpulmonary pressure values obtained using an naso/orogastric tube during the operative procedure to titrate PEEP intraoperatively.

Transpulmonary Pressure Strategy

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults ( 18 years) scheduled for elective surgery expected to last 2 h,
  • elective intraperitoneal abdominal or pelvic surgery including: gastric; biliary; pancreatic; hepatic; major bowel, ovarian, renal tract, bladder, and prostatic; radical hysterectomy; and pelvic exenteration;
  • at least intermediate risk of PPCs defined by a risk score 26

You may not qualify if:

  • Inability or refusal to provide consent
  • Refusal of clinicians caring for patient to follow the protocol
  • Participation in interventional investigation within 30 days of the time of the study
  • Pregnancy
  • Emergency surgery
  • Severe obesity (above Class I, BMI 35)
  • Significant lung disease: any diagnosed or treated respiratory condition that (a) requires home oxygen therapy or non-invasive ventilation, (b) severely limits exercise tolerance to \<4 METs (e.g. patients unable to do light housework, walk flat at 4 miles/h or climb one flight of stairs), or (c) required previous lung surgery80
  • Significant heart disease: cardiac conditions that limit exercise tolerance to \<4 METs
  • Renal failure: peritoneal or hemodialysis requirement or preoperative creatinine 2 mg/dL;
  • Neuromuscular disease that impairs ability to ventilate without assistance
  • Severe chronic liver disease (Child-Pugh Score of 10 -15)
  • Sepsis
  • Malignancy or other irreversible condition for which 6-month mortality is estimated 50%
  • Bone marrow transplant.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

Location

Related Publications (1)

  • Fernandez-Bustamante A, Sprung J, Parker RA, Bartels K, Weingarten TN, Kosour C, Thompson BT, Vidal Melo MF. Individualized PEEP to optimise respiratory mechanics during abdominal surgery: a pilot randomised controlled trial. Br J Anaesth. 2020 Sep;125(3):383-392. doi: 10.1016/j.bja.2020.06.030. Epub 2020 Jul 16.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

January 30, 2016

First Posted

February 2, 2016

Study Start

June 1, 2016

Primary Completion

March 1, 2017

Study Completion

June 1, 2017

Last Updated

February 8, 2019

Record last verified: 2019-02

Locations